SCHEDULE 13G/A: Morgan Stanley Amends Zymeworks Stake, Subsidiary Drops Below 5% Ownership Threshold
Beneficial Ownership Amendment
Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have filed an amended Schedule 13G, disclosing their beneficial ownership in Zymeworks Inc., with Morgan Stanley Capital Services LLC's stake falling below the 5% reporting threshold.
Summary
- Morgan Stanley, as a parent holding company, reported beneficial ownership of 4,055,172 shares of Zymeworks Inc. common stock, representing 5.8% of the class.
- Morgan Stanley Capital Services LLC, a subsidiary of Morgan Stanley, reported beneficial ownership of 3,231,122 shares of Zymeworks Inc. common stock, representing 4.6% of the class.
- Morgan Stanley Capital Services LLC has ceased to be the beneficial owner of more than five percent of Zymeworks Inc.'s common stock as of the event date.
- The filing is an Amendment No. 2 to a Schedule 13G, indicating a change from a previous filing.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing (Schedule 13G) disclosing beneficial ownership. It does not contain information that inherently suggests positive or negative sentiment regarding the issuer's performance or outlook, but rather reflects changes in an institutional investor's passive stake.
Future Outlook
NA
Industry Context
This filing is a routine disclosure of institutional ownership changes, common in the financial industry for large investment firms managing client assets or proprietary trading. It reflects a passive investment position rather than an active strategic move related to Zymeworks' core business.
Stakeholder Impact
- Shareholders: Provides transparency regarding significant institutional ownership and changes in large holder positions, which can influence market perception and liquidity.
- Investors: Offers data points for tracking institutional interest in Zymeworks Inc.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of event which required the filing of this statement, indicating the ownership status. |
| 05/07/2025 | Date the Schedule 13G Amendment No. 2 was signed and filed. |
Keywords
Zymeworks Inc., Morgan Stanley, Morgan Stanley Capital Services LLC, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Institutional Ownership, Investment Management
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.